Why is Shree Ganesh Bio falling/rising?

As of 29-Jul, Shree Ganesh Biotech India Ltd is currently priced at Rs.0.79, showing no change (0.00%). The stock has recently hit a new 52-week low today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has declined by 2.47%, and it has experienced a significant drop of 24.04% year-to-date. Despite these declines, today's performance has outperformed its sector by 0.54%, and there has been a notable increase in investor participation, with delivery volume rising by 22.99% against the 5-day average. However, the company is facing challenges, including operating losses and a weak ability to service its debt, which contributes to its classification as a strong sell.
In the broader market context, the stock's performance has been notably poor compared to the benchmark Sensex, which has only declined by 1.03% over the past week and has gained 4.09% year-to-date. This stark contrast highlights the stock's underperformance, as it has generated a return of -36.29% over the past year, while the Sensex has remained relatively stable with a change of -0.02%. The company's weak long-term fundamental strength, indicated by a low return on equity and negative EBITDA, further exacerbates its challenges in the market, making it a risky investment compared to historical valuations.